How views on US healthcare price transparency are changing
Previously in a series of policy letters, Federal Trade Commission staff expressed concerns that transparency could lead to coordinated behavior and higher...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA experts provide consultation and expert testimony in healthcare matters related to attempted monopolization or collusion and price fixing. Our experts use cutting-edge theory and empirical analyses to distinguish aggressive competition that is procompetitive from business practices that hinder competition or to assess the plausibility of collusion claims and to perform statistical analyses to distinguish between competitive and anti-competitive pricing and payment.
Previously in a series of policy letters, Federal Trade Commission staff expressed concerns that transparency could lead to coordinated behavior and higher...
The Federal Trade Commission and the Department of Justice recently released Draft Vertical Merger Guidelines (VMG), which describe the framework under which...